6 insiders reported 218 Form 4 transactions for Krystal Biotech, Inc. (KRYS) over the past 18 months (most recent 2026-06-26). Recent activity: Thomas John Charles (EVP, General Counsel) Buy 1,000 shares, Thomas John Charles (EVP, General Counsel) Sell 1,000 shares, Krishnan Krish S (President and CEO) Sell 11,461 shares, Krishnan Suma (President, R&D) Sell 320 shares, Krishnan Suma (President, R&D) Sell 593 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Thomas John Charles | EVP, General Counsel | Buy | 1,000 | $179,250 |
| 2026-06-26 | Thomas John Charles | EVP, General Counsel | Sell | 1,000 | $347,270 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 11,461 | $3.5M |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 320 | $96,240 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 593 | $179,235 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 640 | $193,431 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 247 | $74,883 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 176 | $53,358 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 544 | $165,817 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 400 | $121,958 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 589 | $180,429 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 480 | $146,815 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 320 | $96,240 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 1,348 | $413,964 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 4,830 | $1.5M |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 12,729 | $3.9M |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 2,784 | $861,620 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 3,803 | $1.2M |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 2,652 | $823,258 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 2,801 | $868,156 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 964 | $300,149 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 2,039 | $634,001 |
| 2026-06-05 | Krishnan Krish S | President and CEO | Sell | 40 | $12,489 |
| 2026-06-05 | Krishnan Suma | President, R&D | Sell | 240 | $74,796 |
| 2026-03-06 | Krishnan Suma | President, R&D | Sell | 407 | $104,729 |
Source: SEC Form 4 filings · as of 2026-06-26